Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-02-20 @ 4:30 PM
Study NCT ID:
NCT06521567
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-12
First Post:
2024-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
| None | Hodgkin Lymphoma | View |
| None | High and Low Grade Glioma | View |
| None | Glioblastoma Multiforme (GBM) | View |
| None | Diffuse Intrinsic Pontine Glioma (DIPG) | View |
| None | Ependymoma | View |
| None | Osteosarcoma | View |
| None | Hepatic Tumors | View |
| None | Hepatoblastoma | View |
| None | Hepatocellular Carcinoma (HCC) | View |
| None | Fibrolamellar Carcinoma | View |
| None | Rhabdomyosarcoma | View |